From Bench to Bedside – Why Small is Powerful® for Patients

11 September 2018 10:10 - 10:45

  • At the bench: Dissolution study of CESS® nanoparticles vs other particle engineering techniques
  • Into Manufacturing: The GMP Nanoforming process, making clinical material
  • To the bedside: Final Clinical Trial Data for Nanoformed Piroxicam 

David Rowe, Head of Manufacturing, Nanoform

Christian Jones, Chief Commercial Officer, Nanoform

Chris Roe, Senior Research Fellow, Quotient

Claire Wombwell, Senior Scientist, Johnson Matthey